Latest Breaking News On - Tourmaline bio inc - Page 4 : comparemela.com

Tourmaline Bio (NASDAQ:TRML) Shares Down 7 8%

Tourmaline Bio (NASDAQ:TRML) Shares Down 7 8%
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Piper sandlerLeerink partnrsMark mcdadeDimensional fund advisorsTourmaline bio company profileGoldman sachs group incCubist systematic strategiesTourmaline bio incNorthern trust corpJefferies financial groupJump financialTourmaline bioGet free reportFinancial groupDirector mark mcdadeSachs group

Tourmaline Bio (NASDAQ:TRML) Shares Down 7 8%

Shares of Tourmaline Bio, Inc. (NASDAQ:TRML – Get Free Report) traded down 7.8% during trading on Tuesday . The stock traded as low as $38.61 and last traded at $39.33. 64,967 shares were traded during mid-day trading, a decline of 73% from the average session volume of 238,561 shares. The stock had previously closed at […]

Leerink partnrsMark mcdadePiper sandlerTourmaline bio incTourmaline bio company profileGoldman sachs group incCubist systematic strategiesNorthern trust corpDimensional fund advisorsJump financialJefferies financial groupTourmaline bioGet free reportFinancial groupDirector mark mcdadeSachs group

Tourmaline Bio to Present at the Guggenheim Healthcare Talks | 6th Annual Biotechnology Conference

Tourmaline Bio to Present at the Guggenheim Healthcare Talks | 6th Annual Biotechnology Conference
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Sandeep kulkarniTourmaline bio incGuggenheim healthcare talksAnnual biotechnologyHealthcare talksTourmaline bio

Tourmaline Bio (NASDAQ:TRML) Stock Price Up 3 5%

Tourmaline Bio, Inc. (NASDAQ:TRML – Get Free Report)’s stock price rose 3.5% during mid-day trading on Tuesday . The stock traded as high as $38.29 and last traded at $37.80. Approximately 11,465 shares traded hands during trading, a decline of 95% from the average daily volume of 211,499 shares. The stock had previously closed at […]

Sandeep chidambar kulkarniPiper sandlerJefferies financial groupTourmaline bio company profileTourmaline bio incTourmaline bioGet free reportFinancial groupChidambar kulkarniTourmaline bio dailyNasdaq trml

Tourmaline Bio Announces Pricing of Public Offering of Common Stock

NEW YORK, Jan. 25, 2024 Tourmaline Bio, Inc. , a late-stage clinical biotechnology company developing transformative medicines to dramatically improve the lives of patients with life-altering.

New yorkUnited statesPiper sandlerTruist securities incEquity syndicate prospectus departmentExchange commissionGuggenheim securitiesTourmaline bio incProspectus departmentEquity syndicate departmentPiper sandler coTruist securitiesTourmaline bioPrivate securities litigation reform actQuarterly report